3 August 2018 in Science Advances
We present a comprehensive analysis of variation in genes and gene expression of allergens and immunoresponsive proteins in wheat.
12 February 2021 in bioRxiv
Glioblastoma is an aggressive cancer of the brain and spine. While analysis of glioblastoma ‘omics data has somewhat improved our understanding of the disease, it has not led to direct improvement in patient survival. Cancer survival is often characterized by differences in expression of particular genes, but the mechanisms that drive these differences are generally unknown. We therefore set out to model the regulatory mechanisms that associate with glioblastoma survival. We inferred individual patient gene regulatory networks using data from two different expression platforms from The Cancer Genome Atlas (n=522 and 431). We performed a comparative network analysis between patients with long- and short-term survival, correcting for patient age, sex, and neoadjuvant treatment status. We identified seven pathways associated with survival, all of which were involved in immune system signaling. Differential regulation of PD1 signaling was validated in an independent dataset from the German Glioma Network (n=70). We found that transcriptional repression of genes in this pathway—for which treatment options are available—was lost in short-term survivors and that this was independent of mutation burden and only weakly associated with T-cell infiltrate. These results provide a new way to stratify glioblastoma patients that uses network features as biomarkers to predict survival, and identify new potential therapeutic interventions, thus underscoring the value of analyzing gene regulatory networks in individual cancer patients.
25 August 2021 in bioRxiv
Summary: Calpains are cysteine proteases that control cell fate transitions. Although calpains are viewed as modulatory proteases displaying severe, pleiotropic phenotypes in eukaryotes, human calpain targets are also directed to the N-end rule degradatory pathway. Several of these destabilized targets are transcription factors, hinting at a gene regulatory role. Here, we analyze the gene regulatory networks of Physcomitrium patens and characterize the regulons that are deregulated in DEK1 calpain mutants. Predicted cleavage patterns of regulatory hierarchies in the five DEK1-controlled subnetworks are consistent with the gene’s pleiotropy and the regulatory role in cell fate transitions targeting a broad spectrum of functions. Network structure suggests DEK1-gated sequential transition between cell fates in 2D to 3D development. We anticipate that both our method combining phenotyping, transcriptomics and data science to dissect phenotypic traits and our model explaining the calpain’s role as a switch gatekeeping cell fate transitions will inform biology beyond plant development.
6 October 2025 in bioRxiv
Cancer heterogeneity remains a major challenge to the development of broadly effective therapies. Although gene expression-based stratification has advanced our understanding of molecular subtypes, it often overlooks the regulatory mechanisms driving tumor progression and therapeutic resistance. These mechanisms are governed by gene regulatory networks—complex systems of transcription factors and other regulators that control gene expression. To investigate regulatory heterogeneity at the patient level, we inferred individual gene regulatory networks for over 9,000 tumors across 33 cancer types from The Cancer Genome Atlas enabling a comprehensive pancancer analysis of inter-patient regulatory variation. Our analysis uncovered novel regulatory subtypes and revealed recurrent dysregulation of the PD-1 signaling pathway in 23 cancer types. This dysregulation was associated with patient outcomes in 12 cancers and appeared largely independent of established molecular subtypes and immune cell composition, suggesting alternative regulatory mechanisms. We identified both well-characterized (FOS, JUNB, ATF3) and previously unrecognized (RFX7, ELF1, NFYA, NFYC) transcriptional regulators of PD-L1 ( CD274 ), highlighting new candidate targets for modulating immune checkpoint activity across tumor types. Our work demonstrates the power of single-sample gene regulatory networks to uncover hidden layers of tumor biology, improve patient stratification, and inform future research in immunotherapy.
10 November 2025 in bioRxiv
Motivation: Reconstructing and analyzing single-sample regulatory networks has proven useful for understanding mechanisms of regulatory biology and its disruption in disease, but traditionally required a fair amount of programming experience and work from the user. Results: Here, we present SiSaNA ( S ingle- S ample N etwork A nalysis), a workflow that removes the need of prior programming experience and allows for single-sample regulatory network reconstruction and analysis, all via a command line interface. Using example input files, we walk the user through a tutorial on how to run the SiSaNA pipeline, interpret the results, and obtain high-quality figures summarized in a single HTML file as output. Availability: SiSaNA is freely available to install with pip via the Python Package Index. It is additionally available on GitHub at https://github.com/kuijjerlab/sisana . Example input files can be found at https://doi.org/10.5281/zenodo.17190642 .